“AZ 960”的搜索结果

29 个项目

每页

设置降序顺序
  1. TAK-960 hydrochloride

    Catalog No. A21703
    Quick View
    PLK1 inhibitor
    TAK-960 hydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM at 10 μM ATP; TAK-960 hydrochloride also shows inhibitory activities against PLK2 and PLK3, with IC50s of 16.9 and 50.2 nM, respectively. 了解更多
  2. TAK-960

    Catalog No. A11146
    Quick View
    PLK1 抑制剂?
    TAK-960是新型的,口服可用的polo样激酶1选择性抑制剂,具有广谱的临床前抗肿瘤活性。 了解更多
  3. ML167

    Catalog No. A14297
    Quick View
    Clk4 抑制剂
    ML167是一种高度选择性的Cdc2样激酶4(Clk4)抑制剂。 了解更多
  4. Aurora inhibitor 1

    Catalog No. A19637
    Quick View
    Aurora inhibitor
    Aurora inhibitor 1 is a potent Aurora inhibitor with an IC50 of ?? 4 nM and ??13 nM for Aurora A and Aurora B kinase, respectively. 了解更多
  5. BS-181 hydrochloride

    Catalog No. A21988
    Quick View
    CDK7 inhibitor
    BS-181 hydrochloride is a highly selective CDK7 inhibitor with IC50 of 21 nM, and > 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9. 了解更多
  6. SBE13

    Catalog No. A21696
    Quick View
    Plk1 inhibitor
    SBE13 is a potent and selective Plk1 inhibitor, with an IC50 of 200 pM; SBE13 poorly inhibits Plk2 (IC50>66?μM) or Plk3 (IC50=875?nM). 了解更多
  7. Fasudil

    Catalog No. A21628
    Quick View
    ROCK inhibitor
    Fasudil (HA-1077; AT877), is a nonspecific ROCK inhibitor and also has inhibitory effect on protein kinases. 了解更多
  8. LDN-192960 hydrochloride

    Catalog No. A21390
    Quick View
    DYRK2 inhibitor
    LDN-192960 hydrochloride is an inhibitor of Haspin and Dual-specificity Tyrosine-regulated Kinase 2 (DYRK2) with IC50s of 10 nM and 48 nM, respectively. 了解更多
  9. CHK1-IN-2

    Catalog No. A13142
    Quick View
    CHK1 inhibitor
    CHK1-IN-2 is a checkpoint kinase 1 (CHK1) inhibitor, with an IC50 of 6 nM. 了解更多
  10. Abemaciclib Metabolites M2

    Catalog No. A18416
    Quick View
    CDK4/CDK6 inhibitor
    Abemaciclib Metabolites M2 is a metabolite of abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s in the range of 1-3 nM. Anti-cancer activity. 了解更多
  11. KRAS G12C inhibitor 17

    Catalog No. A18441
    Quick View
    KRAS G12C inhibitor
    KRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 82, has an IC50 of 5 nM. 了解更多
  12. KRAS G12C inhibitor 16

    Catalog No. A18444
    Quick View
    KRAS G12C inhibitor
    KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 39, has an IC50 of 97 nM. 了解更多
  13. KRAS G12C inhibitor 15

    Catalog No. A18447
    Quick View
    KRAS G12C inhibitor
    KRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 22, has an IC50 of 5 nM. 了解更多
  14. CDK2-IN-4

    Catalog No. A18667
    Quick View
    CDK2 inhibitor
    CDK2-IN-4 is a potent and selective CDK2 inhibitor with an IC50 of 44 nM for CDK2/cyclin A, shows 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM). 了解更多
  15. KRAS G12C inhibitor 5

    Catalog No. A18840
    Quick View
    KRas G12C inhibitor
    KRAS G12C inhibitor 5 is a KRas G12C inhibitor extracted from patent WO2017201161A1, Compound example 147. 了解更多
  16. KRAS G12C inhibitor 13

    Catalog No. A19041
    Quick View
    KRAS G12C inhibitor
    KRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30. 了解更多
  17. AZD4573

    Catalog No. A18321
    Quick View
    CDK9 inhibitor
    AZD4573 is a potent and selective inhibitor of CDK9, with fast-off binding kinetics and high selectivity versus other kinases, including other CDK family kinases. 了解更多
  18. 6H05

    Catalog No. A16097
    Quick View
    K-Ras 抑制剂
    6H05是致癌突变体K-Ras(G12C)的选择性变构抑制剂。 了解更多
  19. XRP44X

    Catalog No. A16049
    Quick View
    Ras-Net 抑制剂
    XRP44X是Ras-Net(Elk-3)途径抑制剂(IC50 = 10-20 nM)。间接抑制Erk1/2激活上游的净磷酸化。 了解更多
  20. AZD1152

    Catalog No. A15011
    Quick View
    Aurora B 抑制剂
    AZD1152是一种前药,可在血清中迅速经历磷酸酶介导的裂解作用,释放出Barasertib-hQPA(一种选择性的Aurora B激酶抑制剂),在急性髓细胞性白血病(AML)患者的临床研究中显示出初步活性。 了解更多
  21. AZD5597

    Catalog No. A13506
    Quick View
    CDK 抑制剂
    AZD5597是有效的CDK抑制剂,对一系列癌细胞具有体外抗增殖作用。 了解更多
  22. AZ191

    Catalog No. A14314
    Quick View
    DYRK 抑制剂
    AZ191是一种有效的选择性DYRK1B抑制剂,IC50为17 nM,选择性比DYRK1A和DYRK2高5到110倍。 了解更多
  23. MLN 0905

    Catalog No. A12429
    Quick View
    PLK1 抑制剂
    MLN0905是有效的选择性小分子PLK1抑制剂。MLN0905抑制包括DLBCL细胞系在内的多种人类肿瘤细胞的细胞增殖。 了解更多
  24. Azathioprine

    Catalog No. A10107
    Quick View
    Azathioprine是一种免疫抑制药物,可抑制嘌呤合成和GTP结合蛋白Rac1活化,用于治疗器官移植和自身免疫性疾病。 了解更多
  25. AZD5438

    Catalog No. A11105
    Quick View
    CDK 抑制剂
    AZD5438是有效的细胞周期蛋白依赖性激酶(CDK)1、2和9抑制剂(IC50值分别为16、6和20 nM)。 了解更多
  26. MK-1775

    Catalog No. A10599
    Quick View
    WEE1 抑制剂
    MK-1775是一种有效的体外和体内Wee1激酶抑制剂。 了解更多
  27. AZD7762

    Catalog No. A10113
    Quick View
    Chk1 & Chk2 抑制剂
    AZD7762是一种有效的ATP竞争性检查点激酶抑制剂,可促进检查点废止并增强DNA靶向疗法。 了解更多
  28. AZD1152-HQPA (Barasertib)

    Catalog No. A10109
    Quick View
    Aurora Kinase B 抑制剂
    AZD1152-HQPA (Barasertib)是Aurora B的高效抑制剂,Ki值分别为0.36(Aurora B)和1369 nM(Aurora A),与一组其他50种激酶相比具有很高的特异性。 了解更多
  29. Thiazovivin

    Catalog No. A10928
    Quick View
    ROCK 抑制剂
    Thiazovivin是一种Rho相关激酶(ROCK)的选择性抑制剂。 了解更多

29 个项目

每页

设置降序顺序
Rewards